nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—Topoisomerase Inhibitors—Etoposide—germ cell cancer	0.502	1	CiPCiCtD
Mitoxantrone—sarcoma—germ cell cancer	0.241	1	CtDrD
Mitoxantrone—TOP2A—Etoposide—germ cell cancer	0.0263	0.154	CbGbCtD
Mitoxantrone—ABCC1—Dactinomycin—germ cell cancer	0.0258	0.151	CbGbCtD
Mitoxantrone—ABCG2—Dactinomycin—germ cell cancer	0.0173	0.101	CbGbCtD
Mitoxantrone—ABCC1—Vinblastine—germ cell cancer	0.0162	0.0944	CbGbCtD
Mitoxantrone—ABCC1—Etoposide—germ cell cancer	0.0146	0.0851	CbGbCtD
Mitoxantrone—ABCG2—Cisplatin—germ cell cancer	0.00991	0.058	CbGbCtD
Mitoxantrone—ABCG2—Etoposide—germ cell cancer	0.00974	0.0569	CbGbCtD
Mitoxantrone—ABCC1—Methotrexate—germ cell cancer	0.00961	0.0562	CbGbCtD
Mitoxantrone—CYP2E1—Etoposide—germ cell cancer	0.00694	0.0406	CbGbCtD
Mitoxantrone—ABCG2—Methotrexate—germ cell cancer	0.00643	0.0376	CbGbCtD
Mitoxantrone—ABCB1—Dactinomycin—germ cell cancer	0.00622	0.0364	CbGbCtD
Mitoxantrone—CYP3A4—Ifosfamide—germ cell cancer	0.0044	0.0257	CbGbCtD
Mitoxantrone—ABCB1—Vinblastine—germ cell cancer	0.0039	0.0228	CbGbCtD
Mitoxantrone—ABCB1—Cisplatin—germ cell cancer	0.00357	0.0209	CbGbCtD
Mitoxantrone—ABCB1—Etoposide—germ cell cancer	0.00351	0.0205	CbGbCtD
Mitoxantrone—CYP3A4—Vinblastine—germ cell cancer	0.00234	0.0137	CbGbCtD
Mitoxantrone—ABCB1—Methotrexate—germ cell cancer	0.00232	0.0136	CbGbCtD
Mitoxantrone—CYP3A4—Etoposide—germ cell cancer	0.0021	0.0123	CbGbCtD
Mitoxantrone—ABCG2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00109	0.0867	CbGpPWpGaD
Mitoxantrone—ABCG2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000626	0.0498	CbGpPWpGaD
Mitoxantrone—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00059	0.0469	CbGpPWpGaD
Mitoxantrone—BTK—trigeminal ganglion—germ cell cancer	0.000573	0.0291	CbGeAlD
Mitoxantrone—PIM1—trigeminal ganglion—germ cell cancer	0.000496	0.0252	CbGeAlD
Mitoxantrone—SLC47A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000484	0.0384	CbGpPWpGaD
Mitoxantrone—SLC47A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000477	0.0379	CbGpPWpGaD
Mitoxantrone—PIM1—eye—germ cell cancer	0.000427	0.0217	CbGeAlD
Mitoxantrone—BTK—decidua—germ cell cancer	0.000426	0.0216	CbGeAlD
Mitoxantrone—CYP2E1—urine—germ cell cancer	0.000375	0.019	CbGeAlD
Mitoxantrone—PIM1—skin of body—germ cell cancer	0.000372	0.0189	CbGeAlD
Mitoxantrone—SLC47A2—head—germ cell cancer	0.000371	0.0188	CbGeAlD
Mitoxantrone—PIM1—decidua—germ cell cancer	0.000369	0.0187	CbGeAlD
Mitoxantrone—BTK—pituitary gland—germ cell cancer	0.000366	0.0186	CbGeAlD
Mitoxantrone—BTK—medulla oblongata—germ cell cancer	0.000353	0.0179	CbGeAlD
Mitoxantrone—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000339	0.0269	CbGpPWpGaD
Mitoxantrone—ABCG2—HIF-2-alpha transcription factor network—POU5F1—germ cell cancer	0.000337	0.0268	CbGpPWpGaD
Mitoxantrone—BTK—adrenal gland—germ cell cancer	0.000327	0.0166	CbGeAlD
Mitoxantrone—PIM1—uterus—germ cell cancer	0.000323	0.0164	CbGeAlD
Mitoxantrone—PIM1—pituitary gland—germ cell cancer	0.000317	0.0161	CbGeAlD
Mitoxantrone—BTK—bone marrow—germ cell cancer	0.000316	0.0161	CbGeAlD
Mitoxantrone—BTK—spinal cord—germ cell cancer	0.000315	0.016	CbGeAlD
Mitoxantrone—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000312	0.0248	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000307	0.0244	CbGpPWpGaD
Mitoxantrone—PIM1—medulla oblongata—germ cell cancer	0.000306	0.0155	CbGeAlD
Mitoxantrone—BTK—female gonad—germ cell cancer	0.000305	0.0155	CbGeAlD
Mitoxantrone—TOP2A—Vindesine—Vinblastine—germ cell cancer	0.000303	0.291	CbGdCrCtD
Mitoxantrone—CYP3A4—urine—germ cell cancer	0.000302	0.0153	CbGeAlD
Mitoxantrone—PIM1—Ectoderm Differentiation—SOX2—germ cell cancer	0.000286	0.0227	CbGpPWpGaD
Mitoxantrone—PIM1—adrenal gland—germ cell cancer	0.000283	0.0144	CbGeAlD
Mitoxantrone—PIM1—midbrain—germ cell cancer	0.00028	0.0142	CbGeAlD
Mitoxantrone—PIM1—C-MYB transcription factor network—H2AFZ—germ cell cancer	0.000278	0.0221	CbGpPWpGaD
Mitoxantrone—PIM1—bone marrow—germ cell cancer	0.000274	0.0139	CbGeAlD
Mitoxantrone—PIM1—spinal cord—germ cell cancer	0.000273	0.0139	CbGeAlD
Mitoxantrone—BTK—testis—germ cell cancer	0.000271	0.0137	CbGeAlD
Mitoxantrone—SLC47A2—brain—germ cell cancer	0.000269	0.0137	CbGeAlD
Mitoxantrone—PIM1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	0.000269	0.0214	CbGpPWpGaD
Mitoxantrone—SLC47A1—trigeminal ganglion—germ cell cancer	0.000266	0.0135	CbGeAlD
Mitoxantrone—PIM1—female gonad—germ cell cancer	0.000264	0.0134	CbGeAlD
Mitoxantrone—CYP1B1—Metapathway biotransformation—NAT9—germ cell cancer	0.000261	0.0207	CbGpPWpGaD
Mitoxantrone—PIM1—C-MYB transcription factor network—KITLG—germ cell cancer	0.000256	0.0204	CbGpPWpGaD
Mitoxantrone—PIM1—endocrine gland—germ cell cancer	0.000246	0.0125	CbGeAlD
Mitoxantrone—PIM1—head—germ cell cancer	0.000243	0.0123	CbGeAlD
Mitoxantrone—SLC47A1—brainstem—germ cell cancer	0.000235	0.0119	CbGeAlD
Mitoxantrone—PIM1—testis—germ cell cancer	0.000234	0.0119	CbGeAlD
Mitoxantrone—SLC47A1—eye—germ cell cancer	0.000229	0.0116	CbGeAlD
Mitoxantrone—SLC47A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.00022	0.0175	CbGpPWpGaD
Mitoxantrone—TOP2A—decidua—germ cell cancer	0.000217	0.011	CbGeAlD
Mitoxantrone—SLC47A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000217	0.0172	CbGpPWpGaD
Mitoxantrone—PIM1—cerebellum—germ cell cancer	0.000216	0.011	CbGeAlD
Mitoxantrone—BTK—brain—germ cell cancer	0.000203	0.0103	CbGeAlD
Mitoxantrone—SLC47A1—decidua—germ cell cancer	0.000198	0.01	CbGeAlD
Mitoxantrone—BTK—lymph node—germ cell cancer	0.000196	0.00995	CbGeAlD
Mitoxantrone—TOP2A—Vinorelbine—Vinblastine—germ cell cancer	0.000191	0.184	CbGdCrCtD
Mitoxantrone—TOP2A—Podofilox—Etoposide—germ cell cancer	0.000191	0.184	CbGdCrCtD
Mitoxantrone—TOP2A—Teniposide—Etoposide—germ cell cancer	0.000191	0.184	CbGdCrCtD
Mitoxantrone—TOP2A—uterus—germ cell cancer	0.000189	0.00962	CbGeAlD
Mitoxantrone—BTK—Kit receptor signaling pathway—KITLG—germ cell cancer	0.000183	0.0146	CbGpPWpGaD
Mitoxantrone—PIM1—brain—germ cell cancer	0.000176	0.00892	CbGeAlD
Mitoxantrone—PIM1—C-MYB transcription factor network—KIT—germ cell cancer	0.000175	0.0139	CbGpPWpGaD
Mitoxantrone—SLC47A1—gonad—germ cell cancer	0.000174	0.00884	CbGeAlD
Mitoxantrone—SLC47A1—uterus—germ cell cancer	0.000173	0.00878	CbGeAlD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000171	0.0136	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metapathway biotransformation—NAT9—germ cell cancer	0.00017	0.0135	CbGpPWpGaD
Mitoxantrone—SLC47A1—pituitary gland—germ cell cancer	0.00017	0.00863	CbGeAlD
Mitoxantrone—PIM1—lymph node—germ cell cancer	0.00017	0.00862	CbGeAlD
Mitoxantrone—CYP1B1—eye—germ cell cancer	0.000168	0.00852	CbGeAlD
Mitoxantrone—TOP2A—adrenal gland—germ cell cancer	0.000166	0.00844	CbGeAlD
Mitoxantrone—SLC47A1—medulla oblongata—germ cell cancer	0.000164	0.00832	CbGeAlD
Mitoxantrone—TOP2A—Vincristine—Vinblastine—germ cell cancer	0.000163	0.157	CbGdCrCtD
Mitoxantrone—TOP2A—bone marrow—germ cell cancer	0.000161	0.00816	CbGeAlD
Mitoxantrone—TOP2A—female gonad—germ cell cancer	0.000155	0.00787	CbGeAlD
Mitoxantrone—CYP1B1—telencephalon—germ cell cancer	0.000153	0.00777	CbGeAlD
Mitoxantrone—SLC47A1—adrenal gland—germ cell cancer	0.000152	0.00771	CbGeAlD
Mitoxantrone—PIM1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	0.000148	0.0118	CbGpPWpGaD
Mitoxantrone—SLC47A1—spinal cord—germ cell cancer	0.000146	0.00742	CbGeAlD
Mitoxantrone—CYP1B1—skin of body—germ cell cancer	0.000146	0.00741	CbGeAlD
Mitoxantrone—PIM1—GMCSF-mediated signaling events—HRAS—germ cell cancer	0.000146	0.0116	CbGpPWpGaD
Mitoxantrone—ABCG2—trigeminal ganglion—germ cell cancer	0.000145	0.00736	CbGeAlD
Mitoxantrone—CYP1B1—decidua—germ cell cancer	0.000145	0.00736	CbGeAlD
Mitoxantrone—SLC47A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000142	0.0113	CbGpPWpGaD
Mitoxantrone—SLC47A1—female gonad—germ cell cancer	0.000142	0.00718	CbGeAlD
Mitoxantrone—SLC47A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.00014	0.0111	CbGpPWpGaD
Mitoxantrone—ABCC1—telencephalon—germ cell cancer	0.000138	0.00698	CbGeAlD
Mitoxantrone—TOP2A—testis—germ cell cancer	0.000137	0.00698	CbGeAlD
Mitoxantrone—SLC47A1—endocrine gland—germ cell cancer	0.000132	0.00668	CbGeAlD
Mitoxantrone—ABCC1—decidua—germ cell cancer	0.00013	0.00662	CbGeAlD
Mitoxantrone—SLC47A1—head—germ cell cancer	0.00013	0.0066	CbGeAlD
Mitoxantrone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A3—germ cell cancer	0.000128	0.0102	CbGpPWpGaD
Mitoxantrone—CYP1B1—gonad—germ cell cancer	0.000128	0.00648	CbGeAlD
Mitoxantrone—CYP1B1—uterus—germ cell cancer	0.000127	0.00644	CbGeAlD
Mitoxantrone—SLC47A1—testis—germ cell cancer	0.000126	0.00637	CbGeAlD
Mitoxantrone—BTK—Kit receptor signaling pathway—KIT—germ cell cancer	0.000125	0.00993	CbGpPWpGaD
Mitoxantrone—CYP1B1—pituitary gland—germ cell cancer	0.000125	0.00632	CbGeAlD
Mitoxantrone—SLC47A1—cerebellum—germ cell cancer	0.000116	0.00589	CbGeAlD
Mitoxantrone—ABCB1—blood vessel—germ cell cancer	0.000116	0.00588	CbGeAlD
Mitoxantrone—CYP2E1—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.000114	0.00907	CbGpPWpGaD
Mitoxantrone—ABCC1—uterus—germ cell cancer	0.000114	0.00579	CbGeAlD
Mitoxantrone—ABCG2—telencephalon—germ cell cancer	0.000114	0.00578	CbGeAlD
Mitoxantrone—ABCC1—pituitary gland—germ cell cancer	0.000112	0.00569	CbGeAlD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000112	0.00888	CbGpPWpGaD
Mitoxantrone—CYP1B1—adrenal gland—germ cell cancer	0.000111	0.00565	CbGeAlD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.00011	0.00874	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00011	0.00874	CbGpPWpGaD
Mitoxantrone—ABCG2—decidua—germ cell cancer	0.000108	0.00548	CbGeAlD
Mitoxantrone—CYP1B1—female gonad—germ cell cancer	0.000104	0.00527	CbGeAlD
Mitoxantrone—SLC47A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000101	0.00806	CbGpPWpGaD
Mitoxantrone—PIM1—Validated targets of C-MYC transcriptional activation—MYC—germ cell cancer	0.000101	0.00803	CbGpPWpGaD
Mitoxantrone—ABCC1—adrenal gland—germ cell cancer	0.0001	0.00508	CbGeAlD
Mitoxantrone—TOP2A—lymph node—germ cell cancer	9.96e-05	0.00506	CbGeAlD
Mitoxantrone—CYP2E1—telencephalon—germ cell cancer	9.86e-05	0.00501	CbGeAlD
Mitoxantrone—BTK—DAP12 signaling—FGF4—germ cell cancer	9.84e-05	0.00782	CbGpPWpGaD
Mitoxantrone—CYP1B1—endocrine gland—germ cell cancer	9.65e-05	0.0049	CbGeAlD
Mitoxantrone—PIM1—C-MYB transcription factor network—MYC—germ cell cancer	9.62e-05	0.00764	CbGpPWpGaD
Mitoxantrone—CYP1B1—head—germ cell cancer	9.53e-05	0.00484	CbGeAlD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	9.49e-05	0.00754	CbGpPWpGaD
Mitoxantrone—ABCG2—uterus—germ cell cancer	9.44e-05	0.00479	CbGeAlD
Mitoxantrone—SLC47A1—brain—germ cell cancer	9.42e-05	0.00478	CbGeAlD
Mitoxantrone—BTK—IL-5 Signaling Pathway—MYC—germ cell cancer	9.39e-05	0.00746	CbGpPWpGaD
Mitoxantrone—ABCC1—female gonad—germ cell cancer	9.33e-05	0.00474	CbGeAlD
Mitoxantrone—ABCG2—pituitary gland—germ cell cancer	9.28e-05	0.00471	CbGeAlD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—FGF4—germ cell cancer	9.26e-05	0.00736	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—FGF4—germ cell cancer	9.26e-05	0.00736	CbGpPWpGaD
Mitoxantrone—CYP1B1—testis—germ cell cancer	9.2e-05	0.00467	CbGeAlD
Mitoxantrone—SLC47A1—lymph node—germ cell cancer	9.1e-05	0.00462	CbGeAlD
Mitoxantrone—ABCG2—medulla oblongata—germ cell cancer	8.95e-05	0.00454	CbGeAlD
Mitoxantrone—BTK—EPO signaling pathway—HRAS—germ cell cancer	8.81e-05	0.007	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—FGF4—germ cell cancer	8.57e-05	0.00681	CbGpPWpGaD
Mitoxantrone—CYP1B1—cerebellum—germ cell cancer	8.5e-05	0.00431	CbGeAlD
Mitoxantrone—PIM1—Validated targets of C-MYC transcriptional activation—TP53—germ cell cancer	8.3e-05	0.00659	CbGpPWpGaD
Mitoxantrone—ABCG2—adrenal gland—germ cell cancer	8.29e-05	0.00421	CbGeAlD
Mitoxantrone—ABCC1—testis—germ cell cancer	8.28e-05	0.0042	CbGeAlD
Mitoxantrone—BTK—TSLP Signaling Pathway—MYC—germ cell cancer	8.25e-05	0.00655	CbGpPWpGaD
Mitoxantrone—ABCG2—midbrain—germ cell cancer	8.18e-05	0.00415	CbGeAlD
Mitoxantrone—BTK—DAP12 signaling—KITLG—germ cell cancer	8.09e-05	0.00642	CbGpPWpGaD
Mitoxantrone—ABCG2—bone marrow—germ cell cancer	8.02e-05	0.00407	CbGeAlD
Mitoxantrone—ABCG2—spinal cord—germ cell cancer	7.98e-05	0.00405	CbGeAlD
Mitoxantrone—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	7.9e-05	0.00628	CbGpPWpGaD
Mitoxantrone—CYP2E1—medulla oblongata—germ cell cancer	7.75e-05	0.00393	CbGeAlD
Mitoxantrone—ABCG2—female gonad—germ cell cancer	7.73e-05	0.00392	CbGeAlD
Mitoxantrone—ABCC1—cerebellum—germ cell cancer	7.64e-05	0.00388	CbGeAlD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—KITLG—germ cell cancer	7.61e-05	0.00604	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—KITLG—germ cell cancer	7.61e-05	0.00604	CbGpPWpGaD
Mitoxantrone—Anaemia—Dactinomycin—germ cell cancer	7.61e-05	0.00143	CcSEcCtD
Mitoxantrone—Bradycardia—Cisplatin—germ cell cancer	7.6e-05	0.00143	CcSEcCtD
Mitoxantrone—PIM1—C-MYB transcription factor network—HRAS—germ cell cancer	7.55e-05	0.006	CbGpPWpGaD
Mitoxantrone—Erythema—Ifosfamide—germ cell cancer	7.54e-05	0.00142	CcSEcCtD
Mitoxantrone—Acute coronary syndrome—Etoposide—germ cell cancer	7.51e-05	0.00141	CcSEcCtD
Mitoxantrone—Chest pain—Bleomycin—germ cell cancer	7.51e-05	0.00141	CcSEcCtD
Mitoxantrone—Myalgia—Bleomycin—germ cell cancer	7.51e-05	0.00141	CcSEcCtD
Mitoxantrone—Renal failure—Etoposide—germ cell cancer	7.49e-05	0.00141	CcSEcCtD
Mitoxantrone—TOP2A—Gastric Cancer Network 2—MYC—germ cell cancer	7.48e-05	0.00595	CbGpPWpGaD
Mitoxantrone—Myocardial infarction—Etoposide—germ cell cancer	7.47e-05	0.0014	CcSEcCtD
Mitoxantrone—Stomatitis—Etoposide—germ cell cancer	7.43e-05	0.0014	CcSEcCtD
Mitoxantrone—Jaundice—Etoposide—germ cell cancer	7.43e-05	0.0014	CcSEcCtD
Mitoxantrone—Discomfort—Bleomycin—germ cell cancer	7.42e-05	0.0014	CcSEcCtD
Mitoxantrone—Malaise—Dactinomycin—germ cell cancer	7.42e-05	0.0014	CcSEcCtD
Mitoxantrone—Decreased appetite—Vinblastine—germ cell cancer	7.41e-05	0.00139	CcSEcCtD
Mitoxantrone—Ecchymosis—Methotrexate—germ cell cancer	7.38e-05	0.00139	CcSEcCtD
Mitoxantrone—Leukopenia—Dactinomycin—germ cell cancer	7.37e-05	0.00139	CcSEcCtD
Mitoxantrone—Constipation—Vinblastine—germ cell cancer	7.29e-05	0.00137	CcSEcCtD
Mitoxantrone—Pain—Vinblastine—germ cell cancer	7.29e-05	0.00137	CcSEcCtD
Mitoxantrone—Confusional state—Bleomycin—germ cell cancer	7.26e-05	0.00137	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Bleomycin—germ cell cancer	7.2e-05	0.00135	CcSEcCtD
Mitoxantrone—Oedema—Bleomycin—germ cell cancer	7.2e-05	0.00135	CcSEcCtD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	7.2e-05	0.00572	CbGpPWpGaD
Mitoxantrone—CYP2E1—adrenal gland—germ cell cancer	7.17e-05	0.00364	CbGeAlD
Mitoxantrone—Infection—Bleomycin—germ cell cancer	7.15e-05	0.00135	CcSEcCtD
Mitoxantrone—ABCB1—trigeminal ganglion—germ cell cancer	7.15e-05	0.00363	CbGeAlD
Mitoxantrone—Agranulocytosis—Etoposide—germ cell cancer	7.11e-05	0.00134	CcSEcCtD
Mitoxantrone—Vision blurred—Ifosfamide—germ cell cancer	7.11e-05	0.00134	CcSEcCtD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	7.09e-05	0.00563	CbGpPWpGaD
Mitoxantrone—Sepsis—Methotrexate—germ cell cancer	7.08e-05	0.00133	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Bleomycin—germ cell cancer	7.05e-05	0.00133	CcSEcCtD
Mitoxantrone—BTK—B Cell Activation—KITLG—germ cell cancer	7.04e-05	0.00559	CbGpPWpGaD
Mitoxantrone—Feeling abnormal—Vinblastine—germ cell cancer	7.03e-05	0.00132	CcSEcCtD
Mitoxantrone—Myalgia—Dactinomycin—germ cell cancer	7.01e-05	0.00132	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Ifosfamide—germ cell cancer	7e-05	0.00132	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Vinblastine—germ cell cancer	6.97e-05	0.00131	CcSEcCtD
Mitoxantrone—Anaemia—Ifosfamide—germ cell cancer	6.97e-05	0.00131	CcSEcCtD
Mitoxantrone—Discomfort—Dactinomycin—germ cell cancer	6.92e-05	0.0013	CcSEcCtD
Mitoxantrone—CYP2E1—spinal cord—germ cell cancer	6.91e-05	0.00351	CbGeAlD
Mitoxantrone—ABCB1—embryo—germ cell cancer	6.91e-05	0.00351	CbGeAlD
Mitoxantrone—CYP1B1—brain—germ cell cancer	6.9e-05	0.0035	CbGeAlD
Mitoxantrone—Anorexia—Bleomycin—germ cell cancer	6.86e-05	0.00129	CcSEcCtD
Mitoxantrone—ABCG2—testis—germ cell cancer	6.85e-05	0.00348	CbGeAlD
Mitoxantrone—Malaise—Ifosfamide—germ cell cancer	6.8e-05	0.00128	CcSEcCtD
Mitoxantrone—Leukopenia—Ifosfamide—germ cell cancer	6.75e-05	0.00127	CcSEcCtD
Mitoxantrone—Abdominal pain—Vinblastine—germ cell cancer	6.74e-05	0.00127	CcSEcCtD
Mitoxantrone—Hypotension—Bleomycin—germ cell cancer	6.73e-05	0.00127	CcSEcCtD
Mitoxantrone—Oedema—Dactinomycin—germ cell cancer	6.72e-05	0.00126	CcSEcCtD
Mitoxantrone—BTK—Class I PI3K signaling events—HRAS—germ cell cancer	6.71e-05	0.00533	CbGpPWpGaD
Mitoxantrone—Infection—Dactinomycin—germ cell cancer	6.67e-05	0.00125	CcSEcCtD
Mitoxantrone—Arrhythmia—Cisplatin—germ cell cancer	6.67e-05	0.00125	CcSEcCtD
Mitoxantrone—CYP1B1—lymph node—germ cell cancer	6.67e-05	0.00339	CbGeAlD
Mitoxantrone—Alopecia—Cisplatin—germ cell cancer	6.6e-05	0.00124	CcSEcCtD
Mitoxantrone—Cough—Ifosfamide—germ cell cancer	6.58e-05	0.00124	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Dactinomycin—germ cell cancer	6.58e-05	0.00124	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Bleomycin—germ cell cancer	6.56e-05	0.00123	CcSEcCtD
Mitoxantrone—SLC47A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	6.53e-05	0.00519	CbGpPWpGaD
Mitoxantrone—Convulsion—Ifosfamide—germ cell cancer	6.53e-05	0.00123	CcSEcCtD
Mitoxantrone—Hypertension—Ifosfamide—germ cell cancer	6.51e-05	0.00122	CcSEcCtD
Mitoxantrone—Erythema—Cisplatin—germ cell cancer	6.5e-05	0.00122	CcSEcCtD
Mitoxantrone—Paraesthesia—Bleomycin—germ cell cancer	6.47e-05	0.00122	CcSEcCtD
Mitoxantrone—PIM1—Ectoderm Differentiation—MYC—germ cell cancer	6.47e-05	0.00514	CbGpPWpGaD
Mitoxantrone—Dyspnoea—Bleomycin—germ cell cancer	6.42e-05	0.00121	CcSEcCtD
Mitoxantrone—Chest pain—Ifosfamide—germ cell cancer	6.42e-05	0.00121	CcSEcCtD
Mitoxantrone—Myalgia—Ifosfamide—germ cell cancer	6.42e-05	0.00121	CcSEcCtD
Mitoxantrone—Arthralgia—Ifosfamide—germ cell cancer	6.42e-05	0.00121	CcSEcCtD
Mitoxantrone—Renal failure acute—Methotrexate—germ cell cancer	6.42e-05	0.00121	CcSEcCtD
Mitoxantrone—Anorexia—Dactinomycin—germ cell cancer	6.4e-05	0.0012	CcSEcCtD
Mitoxantrone—Discomfort—Ifosfamide—germ cell cancer	6.34e-05	0.00119	CcSEcCtD
Mitoxantrone—ABCG2—cerebellum—germ cell cancer	6.33e-05	0.00321	CbGeAlD
Mitoxantrone—Hypersensitivity—Vinblastine—germ cell cancer	6.28e-05	0.00118	CcSEcCtD
Mitoxantrone—Decreased appetite—Bleomycin—germ cell cancer	6.26e-05	0.00118	CcSEcCtD
Mitoxantrone—CYP2E1—endocrine gland—germ cell cancer	6.22e-05	0.00316	CbGeAlD
Mitoxantrone—ABCC1—brain—germ cell cancer	6.21e-05	0.00315	CbGeAlD
Mitoxantrone—Confusional state—Ifosfamide—germ cell cancer	6.21e-05	0.00117	CcSEcCtD
Mitoxantrone—Pain—Bleomycin—germ cell cancer	6.16e-05	0.00116	CcSEcCtD
Mitoxantrone—Oedema—Ifosfamide—germ cell cancer	6.15e-05	0.00116	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Ifosfamide—germ cell cancer	6.15e-05	0.00116	CcSEcCtD
Mitoxantrone—TOP2A—Gastric Cancer Network 2—TP53—germ cell cancer	6.15e-05	0.00488	CbGpPWpGaD
Mitoxantrone—CYP2E1—head—germ cell cancer	6.14e-05	0.00312	CbGeAlD
Mitoxantrone—Chills—Etoposide—germ cell cancer	6.14e-05	0.00115	CcSEcCtD
Mitoxantrone—Vision blurred—Cisplatin—germ cell cancer	6.13e-05	0.00115	CcSEcCtD
Mitoxantrone—Anaphylactoid reaction—Methotrexate—germ cell cancer	6.12e-05	0.00115	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	6.12e-05	0.00115	CcSEcCtD
Mitoxantrone—Asthenia—Vinblastine—germ cell cancer	6.12e-05	0.00115	CcSEcCtD
Mitoxantrone—Infection—Ifosfamide—germ cell cancer	6.11e-05	0.00115	CcSEcCtD
Mitoxantrone—ABCB1—retina—germ cell cancer	6.11e-05	0.0031	CbGeAlD
Mitoxantrone—Alopecia—Etoposide—germ cell cancer	6.05e-05	0.00114	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Cisplatin—germ cell cancer	6.03e-05	0.00113	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Ifosfamide—germ cell cancer	6.03e-05	0.00113	CcSEcCtD
Mitoxantrone—BTK—DAP12 signaling—FGFR3—germ cell cancer	6.01e-05	0.00477	CbGpPWpGaD
Mitoxantrone—Anaemia—Cisplatin—germ cell cancer	6.01e-05	0.00113	CcSEcCtD
Mitoxantrone—ABCC1—lymph node—germ cell cancer	6e-05	0.00305	CbGeAlD
Mitoxantrone—Skin disorder—Ifosfamide—germ cell cancer	5.98e-05	0.00112	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Ifosfamide—germ cell cancer	5.95e-05	0.00112	CcSEcCtD
Mitoxantrone—Feeling abnormal—Bleomycin—germ cell cancer	5.93e-05	0.00112	CcSEcCtD
Mitoxantrone—CYP2E1—testis—germ cell cancer	5.93e-05	0.00301	CbGeAlD
Mitoxantrone—Anorexia—Ifosfamide—germ cell cancer	5.87e-05	0.0011	CcSEcCtD
Mitoxantrone—Malaise—Cisplatin—germ cell cancer	5.86e-05	0.0011	CcSEcCtD
Mitoxantrone—Decreased appetite—Dactinomycin—germ cell cancer	5.84e-05	0.0011	CcSEcCtD
Mitoxantrone—Diarrhoea—Vinblastine—germ cell cancer	5.83e-05	0.0011	CcSEcCtD
Mitoxantrone—Dysgeusia—Etoposide—germ cell cancer	5.83e-05	0.0011	CcSEcCtD
Mitoxantrone—Leukopenia—Cisplatin—germ cell cancer	5.82e-05	0.00109	CcSEcCtD
Mitoxantrone—Fatigue—Dactinomycin—germ cell cancer	5.79e-05	0.00109	CcSEcCtD
Mitoxantrone—Back pain—Etoposide—germ cell cancer	5.76e-05	0.00108	CcSEcCtD
Mitoxantrone—Hypotension—Ifosfamide—germ cell cancer	5.75e-05	0.00108	CcSEcCtD
Mitoxantrone—Pain—Dactinomycin—germ cell cancer	5.74e-05	0.00108	CcSEcCtD
Mitoxantrone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	5.74e-05	0.00456	CbGpPWpGaD
Mitoxantrone—Urticaria—Bleomycin—germ cell cancer	5.72e-05	0.00108	CcSEcCtD
Mitoxantrone—Body temperature increased—Bleomycin—germ cell cancer	5.69e-05	0.00107	CcSEcCtD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—FGFR3—germ cell cancer	5.65e-05	0.00449	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—FGFR3—germ cell cancer	5.65e-05	0.00449	CbGpPWpGaD
Mitoxantrone—Convulsion—Cisplatin—germ cell cancer	5.63e-05	0.00106	CcSEcCtD
Mitoxantrone—ABCB1—telencephalon—germ cell cancer	5.62e-05	0.00285	CbGeAlD
Mitoxantrone—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	5.61e-05	0.00105	CcSEcCtD
Mitoxantrone—Myalgia—Cisplatin—germ cell cancer	5.53e-05	0.00104	CcSEcCtD
Mitoxantrone—Feeling abnormal—Dactinomycin—germ cell cancer	5.53e-05	0.00104	CcSEcCtD
Mitoxantrone—Paraesthesia—Ifosfamide—germ cell cancer	5.53e-05	0.00104	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Etoposide—germ cell cancer	5.53e-05	0.00104	CcSEcCtD
Mitoxantrone—BTK—DAP12 signaling—KIT—germ cell cancer	5.52e-05	0.00438	CbGpPWpGaD
Mitoxantrone—Anxiety—Cisplatin—germ cell cancer	5.52e-05	0.00104	CcSEcCtD
Mitoxantrone—Anaemia—Etoposide—germ cell cancer	5.5e-05	0.00104	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Dactinomycin—germ cell cancer	5.49e-05	0.00103	CcSEcCtD
Mitoxantrone—Dyspnoea—Ifosfamide—germ cell cancer	5.49e-05	0.00103	CcSEcCtD
Mitoxantrone—CYP2E1—cerebellum—germ cell cancer	5.48e-05	0.00278	CbGeAlD
Mitoxantrone—Somnolence—Ifosfamide—germ cell cancer	5.47e-05	0.00103	CcSEcCtD
Mitoxantrone—Discomfort—Cisplatin—germ cell cancer	5.47e-05	0.00103	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—PVRL2—germ cell cancer	5.47e-05	0.00434	CbGpPWpGaD
Mitoxantrone—Vomiting—Vinblastine—germ cell cancer	5.42e-05	0.00102	CcSEcCtD
Mitoxantrone—BTK—Kit receptor signaling pathway—HRAS—germ cell cancer	5.4e-05	0.00429	CbGpPWpGaD
Mitoxantrone—Malaise—Etoposide—germ cell cancer	5.37e-05	0.00101	CcSEcCtD
Mitoxantrone—Decreased appetite—Ifosfamide—germ cell cancer	5.35e-05	0.00101	CcSEcCtD
Mitoxantrone—Headache—Vinblastine—germ cell cancer	5.34e-05	0.001	CcSEcCtD
Mitoxantrone—Leukopenia—Etoposide—germ cell cancer	5.33e-05	0.001	CcSEcCtD
Mitoxantrone—ABCB1—decidua—germ cell cancer	5.32e-05	0.0027	CbGeAlD
Mitoxantrone—Body temperature increased—Dactinomycin—germ cell cancer	5.31e-05	0.000998	CcSEcCtD
Mitoxantrone—Abdominal pain—Dactinomycin—germ cell cancer	5.31e-05	0.000998	CcSEcCtD
Mitoxantrone—Fatigue—Ifosfamide—germ cell cancer	5.31e-05	0.000998	CcSEcCtD
Mitoxantrone—Oedema—Cisplatin—germ cell cancer	5.31e-05	0.000998	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Cisplatin—germ cell cancer	5.31e-05	0.000998	CcSEcCtD
Mitoxantrone—Hypersensitivity—Bleomycin—germ cell cancer	5.31e-05	0.000998	CcSEcCtD
Mitoxantrone—Infection—Cisplatin—germ cell cancer	5.27e-05	0.000991	CcSEcCtD
Mitoxantrone—Pain—Ifosfamide—germ cell cancer	5.26e-05	0.00099	CcSEcCtD
Mitoxantrone—Constipation—Ifosfamide—germ cell cancer	5.26e-05	0.00099	CcSEcCtD
Mitoxantrone—BTK—Fc-epsilon receptor I signaling in mast cells—HRAS—germ cell cancer	5.26e-05	0.00418	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—FGFR3—germ cell cancer	5.23e-05	0.00416	CbGpPWpGaD
Mitoxantrone—Cough—Etoposide—germ cell cancer	5.2e-05	0.000977	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Cisplatin—germ cell cancer	5.19e-05	0.000977	CcSEcCtD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—KIT—germ cell cancer	5.19e-05	0.00412	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—KIT—germ cell cancer	5.19e-05	0.00412	CbGpPWpGaD
Mitoxantrone—Tachycardia—Cisplatin—germ cell cancer	5.18e-05	0.000974	CcSEcCtD
Mitoxantrone—Asthenia—Bleomycin—germ cell cancer	5.17e-05	0.000971	CcSEcCtD
Mitoxantrone—Convulsion—Etoposide—germ cell cancer	5.16e-05	0.00097	CcSEcCtD
Mitoxantrone—Skin disorder—Cisplatin—germ cell cancer	5.15e-05	0.000969	CcSEcCtD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—AVP—germ cell cancer	5.15e-05	0.00409	CbGpPWpGaD
Mitoxantrone—Hypertension—Etoposide—germ cell cancer	5.14e-05	0.000967	CcSEcCtD
Mitoxantrone—ABCG2—brain—germ cell cancer	5.14e-05	0.00261	CbGeAlD
Mitoxantrone—Hyperhidrosis—Cisplatin—germ cell cancer	5.13e-05	0.000964	CcSEcCtD
Mitoxantrone—Feeling abnormal—Ifosfamide—germ cell cancer	5.07e-05	0.000954	CcSEcCtD
Mitoxantrone—Chest pain—Etoposide—germ cell cancer	5.07e-05	0.000953	CcSEcCtD
Mitoxantrone—Nausea—Vinblastine—germ cell cancer	5.06e-05	0.000952	CcSEcCtD
Mitoxantrone—Anorexia—Cisplatin—germ cell cancer	5.06e-05	0.000951	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Ifosfamide—germ cell cancer	5.03e-05	0.000946	CcSEcCtD
Mitoxantrone—Discomfort—Etoposide—germ cell cancer	5.01e-05	0.000942	CcSEcCtD
Mitoxantrone—CYP3A4—endocrine gland—germ cell cancer	5.01e-05	0.00254	CbGeAlD
Mitoxantrone—ABCG2—lymph node—germ cell cancer	4.97e-05	0.00252	CbGeAlD
Mitoxantrone—Hypotension—Cisplatin—germ cell cancer	4.96e-05	0.000932	CcSEcCtD
Mitoxantrone—Hypersensitivity—Dactinomycin—germ cell cancer	4.95e-05	0.00093	CcSEcCtD
Mitoxantrone—Confusional state—Etoposide—germ cell cancer	4.9e-05	0.000922	CcSEcCtD
Mitoxantrone—Urticaria—Ifosfamide—germ cell cancer	4.89e-05	0.000919	CcSEcCtD
Mitoxantrone—BTK—BCR signaling pathway—HRAS—germ cell cancer	4.88e-05	0.00388	CbGpPWpGaD
Mitoxantrone—Body temperature increased—Ifosfamide—germ cell cancer	4.86e-05	0.000915	CcSEcCtD
Mitoxantrone—Abdominal pain—Ifosfamide—germ cell cancer	4.86e-05	0.000915	CcSEcCtD
Mitoxantrone—Pancytopenia—Methotrexate—germ cell cancer	4.86e-05	0.000914	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Etoposide—germ cell cancer	4.86e-05	0.000914	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Cisplatin—germ cell cancer	4.83e-05	0.000909	CcSEcCtD
Mitoxantrone—Infection—Etoposide—germ cell cancer	4.83e-05	0.000908	CcSEcCtD
Mitoxantrone—Asthenia—Dactinomycin—germ cell cancer	4.82e-05	0.000906	CcSEcCtD
Mitoxantrone—BTK—B Cell Activation—KIT—germ cell cancer	4.8e-05	0.00382	CbGpPWpGaD
Mitoxantrone—Neutropenia—Methotrexate—germ cell cancer	4.79e-05	0.0009	CcSEcCtD
Mitoxantrone—Paraesthesia—Cisplatin—germ cell cancer	4.76e-05	0.000896	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Etoposide—germ cell cancer	4.76e-05	0.000895	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Methotrexate—germ cell cancer	4.76e-05	0.000895	CcSEcCtD
Mitoxantrone—Tachycardia—Etoposide—germ cell cancer	4.74e-05	0.000892	CcSEcCtD
Mitoxantrone—Dyspnoea—Cisplatin—germ cell cancer	4.73e-05	0.000889	CcSEcCtD
Mitoxantrone—Skin disorder—Etoposide—germ cell cancer	4.72e-05	0.000888	CcSEcCtD
Mitoxantrone—Erectile dysfunction—Methotrexate—germ cell cancer	4.72e-05	0.000887	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Etoposide—germ cell cancer	4.7e-05	0.000884	CcSEcCtD
Mitoxantrone—ABCB1—gonad—germ cell cancer	4.69e-05	0.00238	CbGeAlD
Mitoxantrone—ABCB1—uterus—germ cell cancer	4.66e-05	0.00236	CbGeAlD
Mitoxantrone—Anorexia—Etoposide—germ cell cancer	4.63e-05	0.000871	CcSEcCtD
Mitoxantrone—BTK—B Cell Receptor Signaling Pathway—MYC—germ cell cancer	4.62e-05	0.00367	CbGpPWpGaD
Mitoxantrone—Decreased appetite—Cisplatin—germ cell cancer	4.61e-05	0.000867	CcSEcCtD
Mitoxantrone—Diarrhoea—Dactinomycin—germ cell cancer	4.6e-05	0.000864	CcSEcCtD
Mitoxantrone—Pneumonia—Methotrexate—germ cell cancer	4.59e-05	0.000863	CcSEcCtD
Mitoxantrone—Vomiting—Bleomycin—germ cell cancer	4.58e-05	0.000861	CcSEcCtD
Mitoxantrone—ABCB1—pituitary gland—germ cell cancer	4.57e-05	0.00232	CbGeAlD
Mitoxantrone—Drowsiness—Methotrexate—germ cell cancer	4.56e-05	0.000858	CcSEcCtD
Mitoxantrone—Hypotension—Etoposide—germ cell cancer	4.54e-05	0.000854	CcSEcCtD
Mitoxantrone—Rash—Bleomycin—germ cell cancer	4.54e-05	0.000854	CcSEcCtD
Mitoxantrone—Pain—Cisplatin—germ cell cancer	4.54e-05	0.000853	CcSEcCtD
Mitoxantrone—Dermatitis—Bleomycin—germ cell cancer	4.54e-05	0.000853	CcSEcCtD
Mitoxantrone—Hypersensitivity—Ifosfamide—germ cell cancer	4.53e-05	0.000853	CcSEcCtD
Mitoxantrone—Renal failure—Methotrexate—germ cell cancer	4.49e-05	0.000844	CcSEcCtD
Mitoxantrone—CYP2E1—brain—germ cell cancer	4.45e-05	0.00226	CbGeAlD
Mitoxantrone—Stomatitis—Methotrexate—germ cell cancer	4.45e-05	0.000837	CcSEcCtD
Mitoxantrone—Conjunctivitis—Methotrexate—germ cell cancer	4.44e-05	0.000834	CcSEcCtD
Mitoxantrone—Asthenia—Ifosfamide—germ cell cancer	4.42e-05	0.00083	CcSEcCtD
Mitoxantrone—ABCB1—medulla oblongata—germ cell cancer	4.41e-05	0.00224	CbGeAlD
Mitoxantrone—Sweating—Methotrexate—germ cell cancer	4.38e-05	0.000823	CcSEcCtD
Mitoxantrone—Feeling abnormal—Cisplatin—germ cell cancer	4.37e-05	0.000822	CcSEcCtD
Mitoxantrone—TOP2A—Circadian rythm related genes—AVP—germ cell cancer	4.37e-05	0.00347	CbGpPWpGaD
Mitoxantrone—Paraesthesia—Etoposide—germ cell cancer	4.36e-05	0.000821	CcSEcCtD
Mitoxantrone—Haematuria—Methotrexate—germ cell cancer	4.35e-05	0.000818	CcSEcCtD
Mitoxantrone—Dyspnoea—Etoposide—germ cell cancer	4.33e-05	0.000815	CcSEcCtD
Mitoxantrone—Somnolence—Etoposide—germ cell cancer	4.32e-05	0.000813	CcSEcCtD
Mitoxantrone—Nausea—Bleomycin—germ cell cancer	4.28e-05	0.000804	CcSEcCtD
Mitoxantrone—Vomiting—Dactinomycin—germ cell cancer	4.27e-05	0.000803	CcSEcCtD
Mitoxantrone—Agranulocytosis—Methotrexate—germ cell cancer	4.26e-05	0.000801	CcSEcCtD
Mitoxantrone—Rash—Dactinomycin—germ cell cancer	4.23e-05	0.000796	CcSEcCtD
Mitoxantrone—Decreased appetite—Etoposide—germ cell cancer	4.23e-05	0.000794	CcSEcCtD
Mitoxantrone—Diarrhoea—Ifosfamide—germ cell cancer	4.21e-05	0.000792	CcSEcCtD
Mitoxantrone—Body temperature increased—Cisplatin—germ cell cancer	4.19e-05	0.000789	CcSEcCtD
Mitoxantrone—Fatigue—Etoposide—germ cell cancer	4.19e-05	0.000788	CcSEcCtD
Mitoxantrone—Pain—Etoposide—germ cell cancer	4.16e-05	0.000782	CcSEcCtD
Mitoxantrone—Constipation—Etoposide—germ cell cancer	4.16e-05	0.000782	CcSEcCtD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	4.14e-05	0.00329	CbGpPWpGaD
Mitoxantrone—Haemoglobin—Methotrexate—germ cell cancer	4.12e-05	0.000774	CcSEcCtD
Mitoxantrone—Haemorrhage—Methotrexate—germ cell cancer	4.1e-05	0.000771	CcSEcCtD
Mitoxantrone—Hepatitis—Methotrexate—germ cell cancer	4.1e-05	0.000771	CcSEcCtD
Mitoxantrone—ABCB1—adrenal gland—germ cell cancer	4.09e-05	0.00207	CbGeAlD
Mitoxantrone—Pharyngitis—Methotrexate—germ cell cancer	4.07e-05	0.000765	CcSEcCtD
Mitoxantrone—ABCB1—midbrain—germ cell cancer	4.03e-05	0.00205	CbGeAlD
Mitoxantrone—Feeling abnormal—Etoposide—germ cell cancer	4.01e-05	0.000753	CcSEcCtD
Mitoxantrone—Nausea—Dactinomycin—germ cell cancer	3.99e-05	0.00075	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Etoposide—germ cell cancer	3.97e-05	0.000747	CcSEcCtD
Mitoxantrone—ABCB1—bone marrow—germ cell cancer	3.95e-05	0.00201	CbGeAlD
Mitoxantrone—ABCB1—spinal cord—germ cell cancer	3.94e-05	0.002	CbGeAlD
Mitoxantrone—Vomiting—Ifosfamide—germ cell cancer	3.91e-05	0.000736	CcSEcCtD
Mitoxantrone—Hypersensitivity—Cisplatin—germ cell cancer	3.91e-05	0.000735	CcSEcCtD
Mitoxantrone—Rash—Ifosfamide—germ cell cancer	3.88e-05	0.00073	CcSEcCtD
Mitoxantrone—Dermatitis—Ifosfamide—germ cell cancer	3.88e-05	0.000729	CcSEcCtD
Mitoxantrone—Urticaria—Etoposide—germ cell cancer	3.86e-05	0.000726	CcSEcCtD
Mitoxantrone—Abdominal pain—Etoposide—germ cell cancer	3.84e-05	0.000722	CcSEcCtD
Mitoxantrone—Body temperature increased—Etoposide—germ cell cancer	3.84e-05	0.000722	CcSEcCtD
Mitoxantrone—ABCB1—female gonad—germ cell cancer	3.81e-05	0.00193	CbGeAlD
Mitoxantrone—Asthenia—Cisplatin—germ cell cancer	3.81e-05	0.000716	CcSEcCtD
Mitoxantrone—Chills—Methotrexate—germ cell cancer	3.68e-05	0.000691	CcSEcCtD
Mitoxantrone—Nausea—Ifosfamide—germ cell cancer	3.66e-05	0.000687	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	3.65e-05	0.0029	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	3.65e-05	0.0029	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Cisplatin—germ cell cancer	3.63e-05	0.000683	CcSEcCtD
Mitoxantrone—BTK—B Cell Receptor Signaling Pathway—HRAS—germ cell cancer	3.63e-05	0.00288	CbGpPWpGaD
Mitoxantrone—Alopecia—Methotrexate—germ cell cancer	3.62e-05	0.000681	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—FGF4—germ cell cancer	3.6e-05	0.00286	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Etoposide—germ cell cancer	3.58e-05	0.000673	CcSEcCtD
Mitoxantrone—Erythema—Methotrexate—germ cell cancer	3.57e-05	0.000671	CcSEcCtD
Mitoxantrone—ABCG2—Fluoropyrimidine Activity—TP53—germ cell cancer	3.56e-05	0.00283	CbGpPWpGaD
Mitoxantrone—ABCB1—endocrine gland—germ cell cancer	3.54e-05	0.0018	CbGeAlD
Mitoxantrone—ABCB1—head—germ cell cancer	3.5e-05	0.00178	CbGeAlD
Mitoxantrone—Dysgeusia—Methotrexate—germ cell cancer	3.49e-05	0.000657	CcSEcCtD
Mitoxantrone—Asthenia—Etoposide—germ cell cancer	3.49e-05	0.000656	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—FGF4—germ cell cancer	3.45e-05	0.00274	CbGpPWpGaD
Mitoxantrone—Back pain—Methotrexate—germ cell cancer	3.45e-05	0.000649	CcSEcCtD
Mitoxantrone—ABCB1—testis—germ cell cancer	3.38e-05	0.00172	CbGeAlD
Mitoxantrone—Vomiting—Cisplatin—germ cell cancer	3.37e-05	0.000634	CcSEcCtD
Mitoxantrone—Vision blurred—Methotrexate—germ cell cancer	3.36e-05	0.000632	CcSEcCtD
Mitoxantrone—Rash—Cisplatin—germ cell cancer	3.35e-05	0.000629	CcSEcCtD
Mitoxantrone—Dermatitis—Cisplatin—germ cell cancer	3.34e-05	0.000628	CcSEcCtD
Mitoxantrone—Diarrhoea—Etoposide—germ cell cancer	3.33e-05	0.000625	CcSEcCtD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—AVP—germ cell cancer	3.32e-05	0.00264	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PVRL2—germ cell cancer	3.32e-05	0.00263	CbGpPWpGaD
Mitoxantrone—Ill-defined disorder—Methotrexate—germ cell cancer	3.31e-05	0.000622	CcSEcCtD
Mitoxantrone—Anaemia—Methotrexate—germ cell cancer	3.3e-05	0.00062	CcSEcCtD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	3.28e-05	0.0026	CbGpPWpGaD
Mitoxantrone—Malaise—Methotrexate—germ cell cancer	3.22e-05	0.000605	CcSEcCtD
Mitoxantrone—Leukopenia—Methotrexate—germ cell cancer	3.19e-05	0.0006	CcSEcCtD
Mitoxantrone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	3.16e-05	0.00251	CbGpPWpGaD
Mitoxantrone—Nausea—Cisplatin—germ cell cancer	3.15e-05	0.000593	CcSEcCtD
Mitoxantrone—ABCB1—cerebellum—germ cell cancer	3.12e-05	0.00158	CbGeAlD
Mitoxantrone—Cough—Methotrexate—germ cell cancer	3.11e-05	0.000585	CcSEcCtD
Mitoxantrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	3.1e-05	0.00247	CbGpPWpGaD
Mitoxantrone—Convulsion—Methotrexate—germ cell cancer	3.09e-05	0.000581	CcSEcCtD
Mitoxantrone—Vomiting—Etoposide—germ cell cancer	3.09e-05	0.000581	CcSEcCtD
Mitoxantrone—Rash—Etoposide—germ cell cancer	3.06e-05	0.000576	CcSEcCtD
Mitoxantrone—Dermatitis—Etoposide—germ cell cancer	3.06e-05	0.000576	CcSEcCtD
Mitoxantrone—Headache—Etoposide—germ cell cancer	3.04e-05	0.000573	CcSEcCtD
Mitoxantrone—Myalgia—Methotrexate—germ cell cancer	3.04e-05	0.000571	CcSEcCtD
Mitoxantrone—Chest pain—Methotrexate—germ cell cancer	3.04e-05	0.000571	CcSEcCtD
Mitoxantrone—Arthralgia—Methotrexate—germ cell cancer	3.04e-05	0.000571	CcSEcCtD
Mitoxantrone—Discomfort—Methotrexate—germ cell cancer	3e-05	0.000564	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—KITLG—germ cell cancer	2.96e-05	0.00235	CbGpPWpGaD
Mitoxantrone—Confusional state—Methotrexate—germ cell cancer	2.94e-05	0.000552	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Methotrexate—germ cell cancer	2.91e-05	0.000547	CcSEcCtD
Mitoxantrone—Infection—Methotrexate—germ cell cancer	2.89e-05	0.000544	CcSEcCtD
Mitoxantrone—Nausea—Etoposide—germ cell cancer	2.89e-05	0.000543	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	2.87e-05	0.00228	CbGpPWpGaD
Mitoxantrone—Thrombocytopenia—Methotrexate—germ cell cancer	2.85e-05	0.000536	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—KITLG—germ cell cancer	2.84e-05	0.00225	CbGpPWpGaD
Mitoxantrone—Skin disorder—Methotrexate—germ cell cancer	2.83e-05	0.000532	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Methotrexate—germ cell cancer	2.81e-05	0.000529	CcSEcCtD
Mitoxantrone—Anorexia—Methotrexate—germ cell cancer	2.78e-05	0.000522	CcSEcCtD
Mitoxantrone—Hypotension—Methotrexate—germ cell cancer	2.72e-05	0.000512	CcSEcCtD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.71e-05	0.00215	CbGpPWpGaD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	2.69e-05	0.00214	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.67e-05	0.00212	CbGpPWpGaD
Mitoxantrone—Musculoskeletal discomfort—Methotrexate—germ cell cancer	2.65e-05	0.000499	CcSEcCtD
Mitoxantrone—Paraesthesia—Methotrexate—germ cell cancer	2.61e-05	0.000492	CcSEcCtD
Mitoxantrone—Dyspnoea—Methotrexate—germ cell cancer	2.6e-05	0.000488	CcSEcCtD
Mitoxantrone—Somnolence—Methotrexate—germ cell cancer	2.59e-05	0.000487	CcSEcCtD
Mitoxantrone—Dyspepsia—Methotrexate—germ cell cancer	2.56e-05	0.000482	CcSEcCtD
Mitoxantrone—ABCB1—brain—germ cell cancer	2.53e-05	0.00129	CbGeAlD
Mitoxantrone—Decreased appetite—Methotrexate—germ cell cancer	2.53e-05	0.000476	CcSEcCtD
Mitoxantrone—Fatigue—Methotrexate—germ cell cancer	2.51e-05	0.000472	CcSEcCtD
Mitoxantrone—Pain—Methotrexate—germ cell cancer	2.49e-05	0.000468	CcSEcCtD
Mitoxantrone—ABCB1—lymph node—germ cell cancer	2.45e-05	0.00124	CbGeAlD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	2.45e-05	0.00195	CbGpPWpGaD
Mitoxantrone—Feeling abnormal—Methotrexate—germ cell cancer	2.4e-05	0.000451	CcSEcCtD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.38e-05	0.00189	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—HRAS—germ cell cancer	2.38e-05	0.00189	CbGpPWpGaD
Mitoxantrone—Gastrointestinal pain—Methotrexate—germ cell cancer	2.38e-05	0.000448	CcSEcCtD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.35e-05	0.00187	CbGpPWpGaD
Mitoxantrone—Urticaria—Methotrexate—germ cell cancer	2.31e-05	0.000435	CcSEcCtD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—MYC—germ cell cancer	2.31e-05	0.00183	CbGpPWpGaD
Mitoxantrone—Abdominal pain—Methotrexate—germ cell cancer	2.3e-05	0.000433	CcSEcCtD
Mitoxantrone—Body temperature increased—Methotrexate—germ cell cancer	2.3e-05	0.000433	CcSEcCtD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.29e-05	0.00182	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—HRAS—germ cell cancer	2.24e-05	0.00178	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	2.24e-05	0.00178	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.21e-05	0.00176	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—FGFR3—germ cell cancer	2.2e-05	0.00175	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—H2AFZ—germ cell cancer	2.19e-05	0.00174	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Methotrexate—germ cell cancer	2.15e-05	0.000403	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—FGFR3—germ cell cancer	2.11e-05	0.00168	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FGF4—germ cell cancer	2.1e-05	0.00166	CbGpPWpGaD
Mitoxantrone—Asthenia—Methotrexate—germ cell cancer	2.09e-05	0.000393	CcSEcCtD
Mitoxantrone—BTK—B Cell Activation—HRAS—germ cell cancer	2.08e-05	0.00165	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—KIT—germ cell cancer	2.02e-05	0.0016	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Methotrexate—germ cell cancer	1.99e-05	0.000375	CcSEcCtD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	1.97e-05	0.00157	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—KIT—germ cell cancer	1.94e-05	0.00154	CbGpPWpGaD
Mitoxantrone—Vomiting—Methotrexate—germ cell cancer	1.85e-05	0.000348	CcSEcCtD
Mitoxantrone—Rash—Methotrexate—germ cell cancer	1.84e-05	0.000345	CcSEcCtD
Mitoxantrone—Dermatitis—Methotrexate—germ cell cancer	1.83e-05	0.000345	CcSEcCtD
Mitoxantrone—Headache—Methotrexate—germ cell cancer	1.82e-05	0.000343	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.75e-05	0.00139	CbGpPWpGaD
Mitoxantrone—Nausea—Methotrexate—germ cell cancer	1.73e-05	0.000325	CcSEcCtD
Mitoxantrone—BTK—Immune System—KITLG—germ cell cancer	1.72e-05	0.00137	CbGpPWpGaD
Mitoxantrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	1.71e-05	0.00136	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SLC2A3—germ cell cancer	1.52e-05	0.0012	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.43e-05	0.00114	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—TP53—germ cell cancer	1.38e-05	0.00109	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.29e-05	0.00102	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FGFR3—germ cell cancer	1.28e-05	0.00102	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.27e-05	0.00101	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SLC2A3—germ cell cancer	1.27e-05	0.00101	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SLC22A3—germ cell cancer	1.25e-05	0.000993	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.25e-05	0.000993	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SLC2A3—germ cell cancer	1.23e-05	0.000976	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SLC22A3—germ cell cancer	1.21e-05	0.000961	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—KIT—germ cell cancer	1.17e-05	0.000933	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SLC2A3—germ cell cancer	1.12e-05	0.000888	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SLC22A3—germ cell cancer	1.1e-05	0.000874	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.1e-05	0.000874	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CRABP1—germ cell cancer	1.02e-05	0.00081	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CRABP1—germ cell cancer	9.86e-06	0.000783	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CRABP1—germ cell cancer	8.97e-06	0.000713	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—HRAS—germ cell cancer	8.72e-06	0.000692	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGF4—germ cell cancer	8.71e-06	0.000692	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—MYC—germ cell cancer	8.46e-06	0.000672	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—HRAS—germ cell cancer	8.37e-06	0.000665	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC2A3—germ cell cancer	8.02e-06	0.000637	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC22A3—germ cell cancer	7.9e-06	0.000628	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—H2AFZ—germ cell cancer	7.77e-06	0.000618	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MYC—germ cell cancer	7.56e-06	0.000601	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KITLG—germ cell cancer	7.15e-06	0.000568	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CRABP1—germ cell cancer	6.44e-06	0.000512	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—germ cell cancer	6.21e-06	0.000493	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC2A3—germ cell cancer	6.04e-06	0.00048	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC22A3—germ cell cancer	5.95e-06	0.000473	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	5.95e-06	0.000472	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	5.75e-06	0.000457	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGFR3—germ cell cancer	5.32e-06	0.000422	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HRAS—germ cell cancer	5.08e-06	0.000403	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KIT—germ cell cancer	4.88e-06	0.000388	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CRABP1—germ cell cancer	4.85e-06	0.000385	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	4.73e-06	0.000375	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC2A3—germ cell cancer	3.72e-06	0.000296	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC22A3—germ cell cancer	3.67e-06	0.000291	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CRABP1—germ cell cancer	2.99e-06	0.000237	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MYC—germ cell cancer	2.69e-06	0.000213	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HRAS—germ cell cancer	2.11e-06	0.000168	CbGpPWpGaD
